Healthcare

Medical cannabis market to hit $87.41b by 2030

The global advancement of its legislation is a key growth driver.

China’s biopharma sector strikes $30b in oncology licensing deals

Antibody-drug conjugates dominated licensing activity in 2024.

Here’s what’s next for Japan’s mycobacterium tuberculosis tests market

The country accounted for about 4% of the Asia-Pacific market in 2024.

What to expect with APAC’s hospital information systems market?

Thanks to improvements in healthcare infrastructure.

ASEAN point-of-care diagnostics market to hit $1.36b by 2030

Thanks to the rising demand for regular monitoring and early detection.

What lies ahead of the global medical device industry?

Tariffs are complicating regulatory compliance and driving costs for manufacturers.

Global sleep apnea oral appliances market to reach $800m by 2030

Its growth is attributed to the rising number of undiagnosed cases.

US foreign aid cuts pressure health systems in emerging markets

At least 38% of USAID funds have been cut compared to FY 2024-25.

In vitro diagnostics to be valued at $141.9b by 2029

Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.

APAC’s HTA adoption to grow amidst infrastructure, talent challenges

Key markets include Indonesia, the Philippines, and Australia.

Oral proteins and peptides market to hit $24b by 2030

Its expansion is attributed to the prevalence of chronic diseases like diabetes.

Physicians divided over patient choice in biologics vs biosimilars

China’s physicians expressed the highest support amongst surveyed countries.

Singapore’s oncology landscape to advance with histotripsy technology

The approach is an ultrasound-based technique that offers a pain-free alternative.

Healthcare payers lag in digital maturity: report

AI solutions could cut costs and increase revenue for payers.